Clearview Cancer Center

Quick Links:

Clearview News Wire

Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.



Early periods may reduce ovarian cancer survival

Last Updated: 2009-07-24 16:15:05 -0400 (Reuters Health)

July 24, 2009

NEW YORK (Reuters Health) - Women whose menstrual periods start at a young age are less likely to survive ovarian cancer than their peers whose periods start later, new research shows. Similarly, women who have more menstrual cycles over their lifetime also have worse survival.


"Although we have relatively good knowledge about the influence of reproductive factors on the risk of developing ovarian cancer, knowledge is rather limited regarding the reproductive factors that may influence survival after diagnosis with this serious disease," Dr. Cheryl L. Robbins said in a statement.


As reported in the journal Cancer Epidemiology, Biomarkers, and Prevention, Robbins' group analyzed data from 410 women with ovarian cancer who were enrolled in the Cancer and Steroid Hormone study (1980 to 1982). During 9 years of follow-up, 212 women died.


Menstrual period onset before 12 years of age increased the risk of death by 51 percent relative to periods beginning at age 14 or older.


The results also indicate that patients with the highest number of lifetime menstrual cycles were 67 percent more likely to die during follow-up than were those with the lowest number of cycles.


The 15-year survival rates for women with the most lifetime menstrual cycles and those with the fewest were 33.3 and 56.7 percent, respectively.


"The significance of this paper is in suggesting new research directions, not in any immediate treatment changes," Dr. Mary B. Daly, an editorial board member of Cancer Epidemiology, Biomarkers, and Prevention, said in a statement.


SOURCE: Cancer Epidemiology, Biomarkers, and Prevention, July 2009.

Other Articles:

July 27, 2010
Low-risk prostate cancer treated aggressively
July 22, 2010
California city approves marijuana farming
July 22, 2010
No Pap smears for women under 21: guidelines
July 21, 2010
Darker skin doesn't mean melanoma immunity
July 21, 2010
New study backs Avastin in lung cancer
July 19, 2010
Americans turn cold shoulder to sunscreen: poll
July 19, 2010
Lung cancer often recurs more than 5 years after resection
July 16, 2010
U.S. cancer group endorses newer breast cancer drugs
July 15, 2010
Palliative care lacking in much of the world
July 12, 2010
Fish oil might lower breast cancer risk
View All Cancer News